BAYRY BAYER AG S/ADR Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
08:36
Jul 02
Jul 02
Bayer is placing its US glyphosate business into a newly formed entity called Ruveon according.
Bayer is placing its US glyphosate business into a newly formed entity called Ruveon according to the report.
18:40
Jun 25
Jun 25
Bayer secures a major legal victory in the Supreme Court over Roundup weedkiller lawsuits after.
Bayer secures a major legal victory in the Supreme Court over Roundup weedkiller lawsuits after years of costly setbacks.
14:01
Jun 25
Jun 25
Supreme Court ruling shields Bayer from Roundup cancer-warning lawsuits.
Supreme Court ruling shields Bayer from Roundup cancer-warning lawsuits, removing a major legal liability.
17:40
Jun 23
Jun 23
Eli Lilly and Bayer criticize Germany's spending on innovative medicines.
Eli Lilly and Bayer criticize Germany's spending on innovative medicines, warning current policies could undermine pharmaceutical investment attractiveness, as reported by the Financial Times.
05:44
Jun 12
Jun 12
Bayer shares face a make-or-break few weeks with two upcoming court developments key.
Bayer shares face a make-or-break few weeks with two upcoming court developments key to stemming a wipeout in market value.
08:30
Jun 01
Jun 01
Bayer's Monsanto debacle is analyzed in a Breakingviews column highlighting bitter M&A lessons.
Bayer's Monsanto debacle is analyzed in a Breakingviews column highlighting bitter M&A lessons from the acquisition.
06:15
Jun 01
Jun 01
Bayer's Monsanto debacle is analyzed in a Breakingviews column highlighting bitter M&A lessons.
Bayer's Monsanto debacle is analyzed in a Breakingviews column highlighting bitter M&A lessons from the acquisition.
13:00
May 06
May 06
The Bayer licensing agreement is driving stronger-than-expected demand for Corteva's seed technology, positioning the company to become royalty positive ahead of schedule.
HIGH
17:14
Mar 04
Mar 04
Bayer said a US judge granted preliminary approval for its $7.25 billion settlement proposal.
Bayer said a US judge granted preliminary approval for its $7.25 billion settlement proposal aimed at containing its liability from thousands of lawsuits over Roundup weedkiller, which have weighed on the German company for years. https://t.co/3PGGrHg0vV
16:36
Feb 26
Feb 26
Positive Phase 3 trial data for a key drug combination is a significant fundamental catalyst.
Positive Phase 3 trial data for a key drug combination is a significant fundamental catalyst that should drive the stock price higher.
MED
21:43
Feb 18
Feb 18
Bayer faces significant headwinds as its Roundup settlement is met with skepticism.
Bayer faces significant headwinds as its Roundup settlement is met with skepticism, coupled with a direct company warning of negative cash flow and ongoing litigation risk.
MED
14:00
Feb 04
Feb 04
Bayer settlement accelerates Corteva's corn licensing to 2027 (5 years early) and introduces cotton licensing, with a $1B EBITDA upside over 10 years. — Opens new revenue streams for Corteva and potentially increases competitive pressure on Bayer's seed businesses.
HIGH
13:30
Jan 30
Jan 30
Bayer collaboration on Eylea products remains a substantial source of international revenue and profit.
HIGH
08:30
Jan 29
Jan 29
Thermo Fisher's Oncomind DX test was FDA-approved as a companion diagnostic for Bayer's therapy, strengthening Bayer's targeted lung cancer treatment and driving demand for Thermo Fisher's NGS diagnostics.
HIGH
About BAYRY Analyst Coverage
Buzzberg tracks BAYRY (BAYER AG S/ADR) across 5 sources. 0 bullish vs 0 bearish calls from 9 analysts. Sentiment: evenly split. 14 total trade ideas tracked. Latest voices: Bloomberg, zerohedge, FirstSquawk.